Literature DB >> 24370715

Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas.

Juan P Rodrigo1, Patricia Martínez, Eva Allonca, Laura Alonso-Durán, Carlos Suárez, Aurora Astudillo, Juana María García-Pedrero.   

Abstract

Metastasis remains a major cause of mortality in head and neck squamous cell carcinoma (HNSCC). Current clinicopathological features have shown limited predictability for the risk of distant metastasis in individual patients, and therefore more accurate and reliable markers are needed. The aim of this study was to investigate the ability of various molecular markers present in primary tumors to predict the risk of developing distant metastasis. Restrictive clinical criteria were applied for patient selection in order to carry out a case-control study with comparable clinical features on a group-wide basis and a similar risk of metastasis. All patients were surgically treated (with postoperative radiotherapy when appropriate) and classified as stage IV disease. Immunohistochemical analysis was performed for a panel of proteins known to participate in cellular processes relevant to metastatic dissemination (E-cadherin, annexin A2, cortactin, FAK, EGFR, p53, and p-AKT). Results showed that the loss of E-cadherin expression was significantly correlated with the risk of distant metastasis (P = 0.002; log-rank test), while the loss of annexin A2 expression was nearly statistically significant (P = 0.06). None of the other protein markers assessed were associated with the development of distant metastasis. Therefore, according to our data the loss of epithelial adhesion seems to play a central role in the development of metastasis in HNSCC, and more importantly, immunohistochemical assessment of key proteins involved in cell adhesion regulation, such as E-cadherin could represent a useful tool to evaluate easily and routinely the metastatic potential of these carcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370715     DOI: 10.1007/s10585-013-9630-5

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  43 in total

1.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

Authors:  C Y Chung; J E Murphy-Ullrich; H P Erickson
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

2.  Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Carlos Suárez
Journal:  Head Neck       Date:  2011-07-07       Impact factor: 3.147

3.  Expression of E-cadherin in squamous cell carcinomas of the supraglottic larynx with correlations to clinicopathological features.

Authors:  J P Rodrigo; F Domínguez; C Alvarez; C Manrique; A Herrero; C Suárez
Journal:  Eur J Cancer       Date:  2002-05       Impact factor: 9.162

4.  E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.

Authors:  Franz X Bosch; Claudia Andl; Ulrich Abel; Jürgen Kartenbeck
Journal:  Int J Cancer       Date:  2005-05-01       Impact factor: 7.396

5.  Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma.

Authors:  Juan P Rodrigo; Paloma Lequerica-Fernández; Pablo Rosado; Eva Allonca; Juana M García-Pedrero; Juan C de Vicente
Journal:  Head Neck       Date:  2011-04-15       Impact factor: 3.147

6.  Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.

Authors:  Marta Canel; Pablo Secades; Juan-Pablo Rodrigo; Rubén Cabanillas; Agustín Herrero; Carlos Suarez; María-Dolores Chiara
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

Review 7.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.

Authors:  Susan Muller; Ling Su; Mourad Tighiouart; Nabil Saba; Hongzheng Zhang; Dong M Shin; Zhuo Georgia Chen
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

9.  Distant metastasis in malignancies of the head and neck.

Authors:  R Bhatia; S Bahadur
Journal:  J Laryngol Otol       Date:  1987-09       Impact factor: 1.469

Review 10.  Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer.

Authors:  Laura C Kelley; Sohrab Shahab; Scott A Weed
Journal:  Clin Exp Metastasis       Date:  2008-03-07       Impact factor: 5.150

View more
  13 in total

1.  Efficacy of radiation exposure in laryngeal squamous cell carcinoma is mediated by the LAMP3/LAMC2/tenascin-C pathway.

Authors:  Hao Wu; Juanjuan Li; Jianqiu Chen; Yong Yin; Peng Da; Qingwen Chen; Zhenxin Zhang; Jinxing Wang; Guohua Wang; Xiaoxia Qiu
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-07

2.  LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma.

Authors:  Xiaoxia Qiu; Yiwen You; Jianfei Huang; Xudong Wang; Huijun Zhu; Zhiwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Effects of Anesthetic Technique on Postoperative Pulmonary Metastasis in Patients Undergoing Laryngectomy.

Authors:  Xuan-Wei Huang; Xu-Dong Wang; Jie-Lan Lai; Ya-Li Lu; Kun Deng; Ren-Chun Lai
Journal:  Cancer Manag Res       Date:  2020-07-07       Impact factor: 3.989

4.  Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.

Authors:  Xavier León; Carolina Bothe; Jacinto García; Matilde Parreño; Sonia Alcolea; Miquel Quer; Luis Vila; Mercedes Camacho
Journal:  Oncotarget       Date:  2015-11-10

5.  The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.

Authors:  Go Omura; Mizuo Ando; Yasuhiro Ebihara; Yuki Saito; Kenya Kobayashi; Osamu Fukuoka; Ken Akashi; Masafumi Yoshida; Takahiro Asakage; Tatsuya Yamasoba
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

6.  Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.

Authors:  Tomasz Kolenda; Kacper Guglas; Magda Kopczyńska; Anna Teresiak; Renata Bliźniak; Andrzej Mackiewicz; Katarzyna Lamperska; Jacek Mackiewicz
Journal:  Cells       Date:  2019-04-21       Impact factor: 6.600

7.  Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study.

Authors:  Yujiao Li; Xiaomin Ou; Chaosu Hu
Journal:  J Cancer       Date:  2019-01-01       Impact factor: 4.207

8.  Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas.

Authors:  Darío García-Carracedo; Maria Ángeles Villaronga; Saúl Álvarez-Teijeiro; Francisco Hermida-Prado; Iñigo Santamaría; Eva Allonca; Laura Suárez-Fernández; Maria Victoria Gonzalez; Milagros Balbín; Aurora Astudillo; Pablo Martínez-Camblor; Gloria H Su; Juan Pablo Rodrigo; Juana María García-Pedrero
Journal:  Oncotarget       Date:  2016-05-17

9.  Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma.

Authors:  Salvatore Alfieri; Andrea Carenzo; Francesca Platini; Mara S Serafini; Federica Perrone; Donata Galbiati; Andrea P Sponghini; Roberta Depenni; Andrea Vingiani; Pasquale Quattrone; Edoardo Marchesi; Maria F Iannó; Arianna Micali; Elisa Mancinelli; Ester Orlandi; Sara Marceglia; Laura D Locati; Lisa Licitra; Paolo Bossi; Loris De Cecco
Journal:  Cancers (Basel)       Date:  2020-04-09       Impact factor: 6.639

10.  The role of E-cadherin and β-catenin in laryngeal cancer.

Authors:  Carlos Eduardo Nardi; Rogério Aparecido Dedivitis; Ricardo Camillo de Almeida; Leandro Luongo de Matos; Claudio Roberto Cernea
Journal:  Oncotarget       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.